Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer
Zhong, S; Fields, C R; Su, N; Pan, Y-X; Robertson, K D
- 作者Zhong, S; Fields, C R; Su, N; Pan, Y-X; Robertson, K D
- 卷第26卷
- 期第18期
- 印刷ISSN0950-9232
- 文件大小547.17KB
- 发表时间2006
- DOI10.1038/sj.onc.1210041
- 页码2621-2634